Table 1. Demographics.
Subjects | Sex | Age | HDRS | Previous episodes |
Medication | Race | Education (years) |
---|---|---|---|---|---|---|---|
MDD | f | 30 | 1 | 0 | none | More than one race | 17 |
MDD | f | 63 | 39 | 3 | none | Black or African American | 21 |
MDD | f | 63 | 23 | 1 | none | Black or African American | 16 |
MDD | f | 63 | 31 | 1 | none | Black or African American | 13 |
MDD | f | 79 | 19 | 1 | escitalopram | White | 18 |
MDD | f | 70 | 26 | 1 | none | White | 17 |
MDD | m | 83 | 18 | 0 | none | White | 12 |
BD | f | 44 | 21 | 0 | valproic acid, fluoxetine | White | 16 |
BD | f | 29 | 23 | 0 | lamotrigine, fluoxetine | White | 15 |
BD | m | 56 | 19 | 0 | lithium | White | 16 |
BD | m | 45 | 23 | 1 | valproic acid, fluoxetine | Black or African American | 17 |
BD | f | 23 | 29 | 3 | valproic acid, fluoxetine | White | 16 |
BD | m | 48 | 26 | 0 | valproic acid, fluoxetine | White | 17 |
Control | m | 52 | 0 | 0 | none | Black or African American | 13 |
Control | f | 28 | 5 | 0 | none | White | 14 |
Control | m | 41 | 0 | 0 | none | White | 16 |
Control | f | 26 | 1 | 0 | none | Black or African American | 19 |
Control | m | 23 | 3 | 0 | none | Asian | 17 |
Control | f | 24 | 6 | 0 | none | White | 16 |
Control | f | 31 | 1 | 0 | none | Black or African American | 16 |
Control | f | 28 | 5 | 0 | none | White | - |
Control | f | 45 | 0 | 0 | none | White | 16 |
Control | f | 25 | 3 | 0 | none | Black or African American | 16 |